Verified stock metrics
BridgeBio Oncology Therapeutics Key Stock Metrics
Direct answer
BridgeBio Oncology Therapeutics has 7 verified key metrics available.
Market capitalization, valuation, profitability and growth facts share the same observation time.
Only reported values are shown. Missing values are not estimated.
Market data checked November 12, 2026.
Get free BridgeBio Oncology Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Market capitalization
- $205.25M
- Price-to-book ratio
- 0.5x
- Return on equity
- -81.92%
- Dividend yield
- 0%
- 52-week price range
- $1.98 to $14.87
- Profit margin
- 0%
- Debt-to-equity ratio
- 0.78%
Explore related company data
View BridgeBio Oncology Therapeutics's market capitalizationView BridgeBio Oncology Therapeutics's price-to-book ratioView BridgeBio Oncology Therapeutics's return on equityView BridgeBio Oncology Therapeutics's dividend yieldView BridgeBio Oncology Therapeutics's 52-week price rangeView BridgeBio Oncology Therapeutics's profit marginView BridgeBio Oncology Therapeutics's debt-to-equity ratioReturn to BridgeBio Oncology Therapeutics profile